SynthesisPloS one2022
Tuberculosis among refugees and migrant populations: Systematic review.
Synthesis in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.
- Prevalence of latent tuberculosis infection in Malaysia: the first systematic review and meta-analysis.BMC infectious diseases · 2026Pooled it
- Pooled it
- Tuberculosis disease and infection screening among migrants in the Netherlands 2019-2023: a national retrospective observational study.The Lancet regional health. Europe · 2026Article
- A drug-resistant TB cluster in a refugee family with Mendelian susceptibility to mycobacterial disease (MSDM).IJTLD open · 2026Article
- Prevalence of tuberculosis-related chest radiographic abnormalities among individuals with latent tuberculosis infection in Gulf Cooperation Council countries: A systematic review and meta-analysis.New microbes and new infections · 2026Review
- Prevalence and clinical impact of dysglycemia among hospitalized adults with tuberculosis in Lebanon: a 2013-2023 retrospective cohort study.BMC infectious diseases · 2026Article
- Clinical management of XpertBMC infectious diseases · 2026Observational
- Drug-resistant tuberculosis in war and complex emergencies: jeopardising progress towards TB elimination and antimicrobial resistance control - a scoping review and perspective.BMJ global health · 2026Article
- Emergency radiology in displaced populations: imaging and practical challenges.Diagnostic and interventional radiology (Ankara, Turkey) · 2026Review
- Tuberculosis in Tibetan refugee settlements in India: a human rights perspective.Frontiers in public health · 2026Article
- Tuberculosis among foreign-born populations in the Western Pacific Region: emerging trends and analysis from 2008 to 2023.Tropical medicine and health · 2025Article
- Spatial Analysis of Drug-Resistant Tuberculosis in Colombia (2020-2023): Departmental Rates, Clusters, and Associated Factors.Tropical medicine and infectious disease · 2025Article
- Factors associated with survival of tuberculosis patients in Southeast Iran: comparison of stepwise cox regression, survival tree, and random survival forest.BMC public health · 2025Article
- Tuberculosis at the crossroads: urgent actions for migrant and refugee health in a turbulent era.BMJ global health · 2025Review
- First insights into the genetic composition ofJournal of clinical tuberculosis and other mycobacterial diseases · 2025Article
- Differences found in patient characteristics of migrant tuberculosis sub-populations within low TB incidence European countries, 2014-2020.BMC infectious diseases · 2025Article
- Outcome of active TB case finding among a nomadic population in Nigeria.Public health action · 2025Article
- Factors associated with patient and health care system delay among migrant and local tuberculosis patients in Istanbul: a cross-sectional study.BMC health services research · 2025Article
- Geographic mapping and spatiotemporal patterns of tuberculosis in Libya within ten years' period (2015 to 2024).Frontiers in epidemiology · 2025Article
- Tuberculosis in transit: risk factors in Tanzania's high-mobility border regions.The Pan African medical journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis (TB) is an important cause of morbidity and mortality among refugees and migrant populations. These groups are among the most vulnerable populations at increased risk of developing TB. However, there is no systematic review that attempts to summarize TB among refugees and migrant populations. This study aimed to summarize evidence on the magnitude of TB among refugees and migrant populations. The findings of this review will provide evidence to improve TB prevention and control policies in refugees and migrants in refugee camps and in migrant-hosting countries. A systematic search was done to retrieve the articles published from 2014 to 2021 in English language from electronic databases. Key searching terms were used in both free text and Medical Subject Heading (MeSH). Articles which had reported the magnitude of TB among refugees and migrant populations were included in the review. We assessed the risk of bias, and quality of the included studies with a modified version of the Newcastle-Ottawa Scale (NOS). Included studies which had reported incidence or prevalence data were eligible for data synthesis. The results were shown as summary tables. In the present review, more than 3 million refugees and migrants were screened for TB with the data collection period between 1991 and 2017 among the included studies. The incidence and prevalence of TB ranged from 19 to 754 cases per 100,000 population and 18.7 to 535 cases per 100,000 population respectively among the included studies. The current findings show that the most reported countries of origin in TB cases among refugees and migrants were from Asia and Africa; and the incidence and prevalence of TB among refugees and migrant populations is higher than in the host countries. This implies the need to implement and improve TB prevention and control in refugees and migrant populations globally. Trial registration: The protocol of this review was registered on PROSPERO (International prospective register of systematic reviews) with ID number, CRD42020157619.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.